Abstract:Neural stem cells have great potential for the development of novel therapies for nervous system diseases. However, the proliferation of endogenous neural stem cells following brain ischemia is insufficient for central nervous system self-repair. Ginkgolide B has a robust neuroprotective effect. In this study, we investigated the cell and molecular mechanisms underlying the neuroprotective effect of ginkgolide B on focal cerebral ischemia/reperfusion injury in vitro and in vivo. Neural stem cells were treated with 20, 40 and 60 mg/L ginkgolide B in vitro. Immunofluorescence staining was used to assess cellular expression of neuron-specific enolase, glial fibrillary acid protein and suppressor of cytokine signaling 2. After treatment with 40 and 60 mg/L ginkgolide B, cells were large, with long processes. Moreover, the proportions of neuron-specific enolase-, glial fibrillary acid protein- and suppressor of cytokine signaling 2-positive cells increased. A rat model of cerebral ischemia/reperfusion injury was established by middle cerebral artery occlusion. Six hours after ischemia, ginkgolide B (20 mg/kg) was intraperitoneally injected, once a day. Zea Longa's method was used to assess neurological function. Immunohistochemistry was performed to evaluate the proportion of nestin-, neuron-specific enolase- and glial fibrillary acid protein-positive cells. Real-time quantitative polymerase chain reaction was used to measure mRNA expression of brain-derived neurotrophic factor and epidermal growth factor. Western blot assay was used to analyze the expression levels of brain-derived neurotrophic factor and suppressor of cytokine signaling 2. Ginkgolide B decreased the neurological deficit score, increased the proportion of nestin-, neuron-specific enolase- and glial fibrillary acid protein-positive cells, increased the mRNA expression of brain-derived neurotrophic factor and epidermal growth factor, and increased the expression levels of brain-derived neurotrophic factor and suppressor of cytokine signaling 2 in the ischemic penumbra. Together, the in vivo and in vitro findings suggest that ginkgolide B improves neurological function by promoting the proliferation and differentiation of neural stem cells in rats with cerebral ischemia/reperfusion injury.

Ginkgolide B Promotes Cell Growth in Endothelial Progenitor Cells Through Mir-126 and the Akt Signaling Pathway

Ginkgo Biloba Extract Reduces Endothelial Progenitor-Cell Senescence Through Augmentation of Telomerase Activity

Ginkgolide B Promotes Proliferation and Functional Activities of Bone Marrow-Derived Endothelial Progenitor Cells: Involvement of Akt/Enos and Mapk/P38 Signaling Pathways

Effects of Ginkgo Biloba Extract on Number and Activity of Endothelial Progenitor Cells from Peripheral Blood

Ginkgolide B Enhances the Differentiation of Preosteoblastic MC3T3-E1 Cells Through VEGF: Involvement of the P38 MAPK Signaling Pathway.

Extract of Ginkgo Biloba Promotes Bovine Aortic Endothelial Cells Growth

Ginkgolide B Suppresses TLR4-Mediated Inflammatory Response by Inhibiting the Phosphorylation of JAK2/STAT3 and p38 MAPK in High Glucose-Treated HUVECs.

Effect of Glucagon Like Peptide-1 on Proliferation and Differentiation of Endothelial Progenitor Cells and Its Mechanism

Ginkgolide B promotes the proliferation and differentiation of neural stem cells following cerebral ischemia/reperfusion injury, both in vivo and in vitro

Ginkgolide B Inhibits Lung Cancer Cells Promotion Via Beclin-1-dependent Autophagy

Glucagon-like Peptide-1 Improves Proliferation and Differentiation of Endothelial Progenitor Cells Via Upregulating VEGF Generation.

Influence of drug-serum containing Dangguibuxue decoction on functional activity and PI3K/Akt pathway of endothelial progenitor cells

Anti-atherosclerotic Effects and Molecular Targets of Ginkgolide B from Ginkgo Biloba

Platelet‑derived Growth Factord Promotes the Angiogenic Capacity of Endothelial Progenitor Cells

Ginkgolide B targets and inhibits creatine kinase B to regulate the CCT/TRiC-SK1 axis and exerts pro-angiogenic activity in middle cerebral artery occlusion mice

Naringin Enhances Endothelial Progenitor Cell (EPC) Proliferation and Tube Formation Capacity Through the CXCL12/CXCR4/PI3K/Akt Signaling Pathway.

Ginkgolide B Blocks Vascular Remodeling after Vascular Injury via Regulating Tgf β 1/Smad Signaling Pathway

Effects of Ginkgolide B on Proliferation, Phagocytosis, NO and ROS Production of Murine Peritoneal Macrophages in Vitro

Ginkgetin effectively mitigates collagen and AA‐induced platelet activation via PLCγ2 but not cyclic nucleotide‐dependent pathway in human

Ginkgolide B Inhibits Hydrogen Peroxide‑induced Apoptosis and Attenuates Cytotoxicity Via Activating the PI3K/Akt/mTOR Signaling Pathway in H9c2 Cells.

Glycogen synthase kinase 3β inhibition enhanced proliferation, migration and functional re-endothelialization of endothelial progenitor cells in hypercholesterolemia microenvironment